MADDEN SECURITIES Corp Invests $1.38 Million in Intuitive Surgical, Inc. (NASDAQ:ISRG)
MADDEN SECURITIES Corp acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 2,415 shares of the medical equipment provider’s stock, valued at approximately $1,376,000. Intuitive Surgical accounts for approximately 1.2% of MADDEN SECURITIES Corp’s investment portfolio, making the stock its 25th biggest position.
Several other hedge funds and other institutional investors have also recently modified their holdings of ISRG. TFG Advisers LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $25,000. 1776 Wealth LLC grew its stake in Intuitive Surgical by 72.2% in the 1st quarter. 1776 Wealth LLC now owns 62 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 26 shares during the period. Virtus ETF Advisers LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at $31,000. Red Door Wealth Management LLC acquired a new stake in Intuitive Surgical in the 1st quarter valued at $33,000. Finally, Gemmer Asset Management LLC grew its stake in Intuitive Surgical by 89.7% in the 1st quarter. Gemmer Asset Management LLC now owns 74 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 35 shares during the period. 87.24% of the stock is currently owned by institutional investors and hedge funds.
Shares of Intuitive Surgical stock traded up $14.05 on Tuesday, reaching $585.34. 541,766 shares of the company were exchanged, compared to its average volume of 843,415. Intuitive Surgical, Inc. has a 1-year low of $360.50 and a 1-year high of $619.00. The company has a market cap of $67.16 billion, a P/E ratio of 49.21, a price-to-earnings-growth ratio of 13.04 and a beta of 0.93. The stock’s 50 day moving average price is $573.90 and its 200-day moving average price is $549.35.
In related news, SVP Jamie Samath sold 248 shares of the company’s stock in a transaction that occurred on Tuesday, April 21st. The stock was sold at an average price of $506.18, for a total value of $125,532.64. Following the completion of the transaction, the senior vice president now directly owns 385 shares of the company’s stock, valued at $194,879.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP David J. Rosa sold 17,950 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $553.49, for a total value of $9,935,145.50. Following the completion of the sale, the executive vice president now owns 37,269 shares of the company’s stock, valued at approximately $20,628,018.81. The disclosure for this sale can be found here. Insiders sold 34,223 shares of company stock valued at $18,611,408 over the last ninety days. 1.60% of the stock is currently owned by corporate insiders.
A number of equities research analysts recently issued reports on the stock. UBS Group dropped their price target on shares of Intuitive Surgical from $620.00 to $565.00 and set a “neutral” rating on the stock in a research note on Friday, April 17th. Raymond James dropped their price target on shares of Intuitive Surgical from $660.00 to $600.00 and set an “outperform” rating on the stock in a research note on Monday, April 13th. OTR Global cut shares of Intuitive Surgical to a “positive” rating in a research note on Tuesday, June 16th. Wells Fargo & Co lifted their price target on shares of Intuitive Surgical from $561.00 to $632.00 and gave the company an “overweight” rating in a research note on Thursday, June 4th. Finally, JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $565.00 to $600.00 and gave the company an “overweight” rating in a report on Thursday, June 18th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $580.32.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Recommended Story: What does it mean to hold a stock in street name?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.